Clinical decision-making should include personalized tangible goals for weight management interventions, including lifestyle modifications, dietary changes, physical activity, and, when appropriate, pharmacotherapy such as medications like tirzepatide [7]
De-tan treatments are specifically crafted to target sun-induced damage, including pigmentation
The use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus does not increase the risk of pancreatic cancer: a U.S.-based cohort study
Ipamorelin is a selective ghrelin receptor agonist commonly studied for its targeted signaling profile and controlled endocrine pathway activation
Zeng Y, Li C, Guan M, Zheng Z, Li J, Xu W, et al